arginyl-glycyl-aspartic acid has been researched along with Ascites in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, RD; Barker, SD; Barnes, MN; Bauerschmitz, GJ; Blackwell, JL; Curiel, DT; Hemminki, A; Kanerva, A; Lam, JT; Siegal, GP; Straughn, JM; Wang, M | 1 |
| Ando, Y; Asakura, S; Asano, Y; Homma, S; Kusano, E; Masunaga, Y; Matsuda, M; Muto, S | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Ascites
| Article | Year |
|---|---|
Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids.
Topics: Adenoviridae; Ascites; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Integrins; Oligopeptides; Ovarian Neoplasms; Spheroids, Cellular; Tumor Cells, Cultured; Virus Replication | 2003 |
Multimeric vitronectin in ascites is involved in fibroblast spreading of EPS in patients on CAPD therapy.
Topics: Animals; Antibodies; Ascites; Fibrinolytic Agents; Fibroblasts; Heparin; Humans; Male; Middle Aged; Oligopeptides; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Sclerosis; Vitronectin | 2003 |